MedCity INVEST Digital Health 2026 - Transforming Healthcare Through Tech
Investors back digital health, but many tools still must prove ROI and deliver better outcomes, lower costs, and improved efficiency.
Good to know
Highlights
- 10 hours
- In person
Refund Policy
Location
Pegasus Park Drive
3000 Pegasus Park Drive
Dallas, TX 75247
How do you want to get there?
Agenda
From Lab to Living Room: The Rise of Consumer Diagnostics
From gut health analysis to STI check-ups to whole-body biomarker testing, patients are increasingly turning to direct-to-consumer diagnostics platforms for answers about their health. In this session, leaders from startups in this space will talk about the level of personalization, clinical rigor and consumer engagement needed in order for people to navigate this type of personal health data.
How Convenience Is Reshaping Clinical Strategy
Patients’ evolving preferences and expectations have forced health systems and digital health companies to rethink how care is delivered. This panel will dive into how providers are offering patients the level of consumer-centric convenience they’ve become accustomed to in other areas of their life — and how this shift can lead to improved loyalty, adherence and outcomes.
Cutting Out the Middlemen: The New Age of Consumer Drug Platforms
Consumers want healthcare to work like retail, with transparent pricing, home delivery, intuitive digital experiences and on-demand access. In response, drugmakers are reshaping how patients access and purchase medications by launching direct-to-consumer platforms that bypass middlemen, which could bring pharma closer to the patient than ever before. Hear pharma leaders explore how consumer-facing models are challenging traditional healthcare distribution channels, as well as discuss whether these new platforms can improve affordability and adherence.